share_log

Mereo BioPharma Group Q2 EPS $(0.02)

Benzinga ·  Aug 13 20:26

Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.02) per share.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment